Dallas, Texas (TX) Commercial Medical Research Companies

Featured companies
Bellair Medical Center
3500 Gaston Avenue # 640
Dallas TX 75246
(214) 820-7117
Institute of Metabolic Disease
3812 Elm St.
Dallas TX 75226
(214) 820-4533
J K & L Clinical Consulting
4365 Fawnhollow Drive
Dallas TX 75244
(972) 661-1165
Not satisfied? Select a reasonRate this pageSend feedback

Or try our search form or quick navigation by category and location

Markets And Markets LLC
17304 Preston Road # 800
Dallas TX 75252
(888) 600-6441
Meruvax Pharma LLC
9982 Monroe Drive # 402
Dallas TX 75220
(469) 531-5810
Omni Med Corp
5430 Lyndon B Johnson Freeway # 1500
Dallas TX 75240
(972) 661-2024
Phamaceutical Research
5499 Glen Lkes Drive # 100
Dallas TX 75231
(214) 891-0062
Pharmaceutical Research
5499 Glen Lakes Drive # 200
Dallas TX 75231
(214) 361-5555
Practice Research Organization Inc
7777 Forest Lane # D570
Dallas TX 75230
(972) 566-6262
Research Across America
9 Medical Parkway # 202
Dallas TX 75234
(972) 241-1222
Rodney Johnson
3419 South Ewing Avenue
Dallas TX 75216
(214) 986-0327
Stand-By Systems Inc
9107 Devonshire Drive
Dallas TX 75209
(214) 368-0251

Stand-By Systems Inc is a privately held company in Dallas, TX and is a Single Location business.
Synechion Inc
6757 Arapaho Road # 711
Dallas TX 75248
(972) 931-5596
Whereorg has 13 results under Commercial Medical Research Companies in Dallas, TX.

Other locations for category Commercial Medical Research


Top Stories
UBS flags buyback possibility after Second-quarter earnings beat
UBS , the world's largest wealth manager, on Tuesday signalled the possibility of resuming share buybacks later this year after generating more income than expected in the first six months and as it boosted...
Tue, Jul 21 2020
Greece calls EU recovery fund deal a 'national success'
Prime Minister Kyriakos Mitsotakis called a European Union deal on a post-pandemic recovery fund a "national success" that would allocate Greece around 72 billion euros ($82.38 billion) to help deal with...
Tue, Jul 21 2020
UBS second-quarter net profit dips as Swiss business dampens trading bonanza
UBS , the world's largest wealth manager, saw net profit drop 11% in the second quarter as higher trading activity failed to offset a pandemic-induced slump in retail and corporate banking.
Tue, Jul 21 2020